| abstract |
The invention relates to the use of at least one HMG-Coenzyme A-reductase inhibitor as an anti-aging active in a cosmetic and / or dermatological composition. It also relates to the use of at least one HMG-Coenzyme A-reductase inhibitor to combat wrinkles and / or fine lines and / or spots on human skin and / or to revive the radiance of the skin and / or to treat acne.n n n The invention also relates to a cosmetic composition for topical use containing at least one HMG-Coenzyme A-reductase inhibitor and at least one active agent having desquamating properties, acting in synergy. |